CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+4.05%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$6.32B
AUM Growth
+$456M
(+7.8%)
Cap. Flow
+$215M
Cap. Flow
% of AUM
3.4%
Top 10 Holdings %
Top 10 Hldgs %
17.62%
Holding
847
New
72
Increased
349
Reduced
257
Closed
60
Top Buys
| 1 |
Broadcom
AVGO
|
$37.2M |
| 2 |
Bristol-Myers Squibb
BMY
|
$30.1M |
| 3 |
Biogen
BIIB
|
$28.3M |
| 4 |
Home Depot
HD
|
$23.7M |
| 5 |
Cisco
CSCO
|
$20.7M |
Top Sells
| 1 |
JPMorgan Chase
JPM
|
$22.4M |
| 2 |
TJX Companies
TJX
|
$20.9M |
| 3 |
Intuit
INTU
|
$15.7M |
| 4 |
FedEx
FDX
|
$15M |
| 5 |
lululemon athletica
LULU
|
$13.4M |
Sector Composition
| 1 | Healthcare | 25.18% |
| 2 | Technology | 17.2% |
| 3 | Financials | 12.85% |
| 4 | Consumer Discretionary | 10.2% |
| 5 | Communication Services | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AABA
401
DELISTED
Altaba Inc. Common Stock
AABA
| $2.78M | 0.04% |
38,000
| – | – |
|
402
Loews
L
$20B
| $2.75M | 0.04% |
56,902
+23,571
| +71% | +$1.14M |
|
403
Masco
MAS
$15.9B
| $2.74M | 0.04% |
73,131
+9,889
| +16% | +$370K |
|
404
Intellia Therapeutics
NTLA
$1.29B
| $2.73M | 0.04% |
99,700
+19,700
| +25% | +$539K |
|
405
Constellation Brands
STZ
$26.2B
| $2.72M | 0.04% |
12,404
-1,031
| -8% | -$226K |
|
406
UGI
UGI
$7.43B
| $2.71M | 0.04% |
52,123
-45,217
| -46% | -$2.35M |
|
407
Kinross Gold
KGC
$26.9B
| $2.68M | 0.04% |
712,740
-829,505
| -54% | -$3.12M |
|
|
SJR
408
DELISTED
Shaw Communications Inc.
SJR
| $2.68M | 0.04% |
131,739
-168,168
| -56% | -$3.42M |
|
409
Heron Therapeutics
HRTX
$201M
| $2.68M | 0.04% |
+69,000
| New | +$2.68M |
|
|
BOLD
410
DELISTED
Audentes Therapeutics, Inc
BOLD
| $2.66M | 0.04% |
69,500
+11,500
| +20% | +$439K |
|
411
Ametek
AME
$43.3B
| $2.65M | 0.04% |
36,713
-16,473
| -31% | -$1.19M |
|
412
STAAR Surgical
STAA
$1.38B
| $2.64M | 0.04% |
85,000
-28,000
| -25% | -$868K |
|
413
Madrigal Pharmaceuticals
MDGL
$9.65B
| $2.63M | 0.04% |
+9,400
| New | +$2.63M |
|
414
Dentsply Sirona
XRAY
$2.92B
| $2.62M | 0.04% |
59,796
-2,514
| -4% | -$110K |
|
415
Kroger
KR
$44.8B
| $2.61M | 0.04% |
91,826
+18,446
| +25% | +$525K |
|
416
Fidelity National Information Services
FIS
$35.9B
| $2.6M | 0.04% |
24,498
-646
| -3% | -$68.5K |
|
417
ServiceNow
NOW
$190B
| $2.6M | 0.04% |
15,055
-508
| -3% | -$87.6K |
|
418
Parker-Hannifin
PH
$96.1B
| $2.59M | 0.04% |
16,632
-4,312
| -21% | -$672K |
|
419
Equinix
EQIX
$75.7B
| $2.58M | 0.04% |
5,992
+3
| +0.1% | +$1.29K |
|
420
Amphenol
APH
$135B
| $2.54M | 0.04% |
116,704
+5,336
| +5% | +$116K |
|
421
Lumen
LUMN
$4.87B
| $2.54M | 0.04% |
136,113
-64,856
| -32% | -$1.21M |
|
422
Fiserv
FI
$73.4B
| $2.54M | 0.04% |
34,205
-13,621
| -28% | -$1.01M |
|
423
M&T Bank
MTB
$31.2B
| $2.53M | 0.04% |
14,852
-678
| -4% | -$115K |
|
|
ONCE
424
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $2.52M | 0.04% |
+30,400
| New | +$2.52M |
|
425
Halozyme
HALO
$8.76B
| $2.48M | 0.04% |
147,000
+25,000
| +20% | +$422K |
|